PPARγ在大鼠实验性牙周炎中发挥双重作用
研究在大鼠实验性牙周炎模型中腹腔注射PPARγ激动剂、拮抗剂或溶剂,观察1、4、8周牙槽骨丢失、炎症因子和骨代谢指标。结果显示激动剂短期减少骨丢失和炎症,长期却增加骨吸收;拮抗剂趋势相反。提示PPARγ在牙周炎进展中具有双重作用。
要点
- PPARγ激动剂短期抑制炎症、减少骨吸收,长期激活则增加骨吸收。
- PPARγ拮抗剂在8周时促进牙槽骨形成,趋势与激动剂相反。
- 临床需关注PPARγ靶向药物对牙周骨代谢的时间依赖性影响。
核心结论
- 在牙周炎进展中,PPARγ短期抑制炎症和骨吸收,但长期激活导致骨吸收增加。
- PPARγ拮抗剂可增强牙槽骨形成。
研究设计与样本
- 通过下颌第一磨牙颈部丝线结扎诱导实验性牙周炎,腹腔注射给药。
- 在1、4、8周评估牙槽骨丢失、炎症和骨代谢因子及破骨细胞计数。
主要发现
- 激动剂组牙槽骨丢失在1周显著减少,8周显著增加;拮抗剂组趋势相反。
- 激动剂在1和4周降低部分炎症因子,8周下调OPG、RUNX2、BMP-2并上调RANKL;拮抗剂作用相反。
- 激动剂1周显著减少破骨细胞计数,8周增加。
临床怎么用
- 短期使用PPARγ激动剂可能有助于控制牙周炎症和骨吸收。
- 长期使用PPARγ激动剂需警惕牙槽骨吸收风险。
- PPARγ拮抗策略可能促进牙槽骨形成,但需进一步验证。
局限性
- 研究为大鼠实验性牙周炎模型,结果外推到人类需谨慎。
- 未报告样本量、P值等详细统计信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate the effects of peroxisome proliferator-activated receptor γ (PPARγ) on inflammation control and bone remodelling in experimental periodontitis in rats. MATERIALS AND METHODS: Experimental periodontitis was induced in rats by thread ligation around cervixes of mandibular first molars. PPARγ agonist, antagonist and vehicle were intraperitoneally administrated, respectively, into rats. Ninety-six male SD rats were randomly divided into control, ligation + vehicle, ligation + agonist and ligation + antagonist groups. After 1, 4 and 8 weeks, alveolar bone loss was assessed by Micro-CT and HE staining. Inflammation and bone metabolism factors were evaluated by ELISA and immunohistochemical examination. Osteoclasts were quantified by tartrate-resistant acid phosphatase (TRAP) staining. RESULTS: Alveolar bone loss was significantly reduced after 1 week, while significantly increased after 8 weeks in agonist group, but antagonist group showed the opposite trend. Agonist decreased some inflammatory cytokines expression after 1 and 4 weeks, downregulated OPG, RUNX2, BMP-2 and upregulated RANKL after 8 weeks, but antagonist brought the opposite effect. PPARγ agonist significantly reduced osteoclast counting after 1 week, while increased it after 8 weeks. CONCLUSIONS: During periodontitis progression, PPARγ could inhibit inflammation, prevent bone resorption within a short time, while the long-term PPARγ activation would lead to increased bone resorption, and PPARγ repression by antagonist would enhance alveolar bone formation.
引用
- Qiao W, Wang C, Huang W, et al. Peroxisome proliferator-activated receptor γ plays dual roles on experimental periodontitis in rats. J Clin Periodontol. 2018. PMID: 29574908. doi:10.1111/jcpe.12891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。